Chapter 45

  1. Anonymous. 2000. Biological and chemical terrorism: strategic plan for preparedness and response. MMWR Recomm Rep 49:1-14.
  2. 1a. Ari TB, Gershunov A, Tristan R, et al. 2010. Interannual variability of human plague occurrence in the western United States explained by tropical and north Pacific ocean climate variability. Am J Trop Med Hyg 83:624-632.
  3. Ayyadurai S, Houhamdi L, Lepidi H, et al. 2008. Long-term persistence of virulent Yersinia pestis in soil. Microbiology 154:2865-2871.
  4. Behr M. 1997. Clarification about plague and its diagnosis. J Am Vet Med Assoc 211:698.
  5. Boulanger LL, Ettestad P, Fogarty JD, et al. 2004. Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in New Mexico, 1985-1989. Clin Infect Dis 38:663-669.
  6. Bronson LR, Smith CR. 2002. Use of liquid deltamethrin in modified, host-targeted bait tubes for control of fleas on sciurid rodents in northern California. J Vector Ecol 27:55-62.
  7. Byrne WR, Welkus SL, Pitt ML, et al. 1998. Antibiotic treatment of experimental pneumonic plague in mice. Antimicrob Agents Chemother 42:675-681.
  8. Carlson ME. 1996. Yersinia pestis infection in cats. Feline Pract 24:22-24.
  9. Chomel BB, Jay MT, Smith CR, et al. 1994. Serological surveillance of plague in dogs and cats: California 1979-1991. Comp Immunol Microbiol Infect Dis 17:111-123.
  10. Craven RB, Maupin GO, Beard ML, et al. 1991. Reported cases of human plague infection in the United States 1970-1991. J Med Entomol 30:758-761.
  11. Davis RM. 1999. Use of orally administered chitin inhibitor (lufenuron) to control flea vectors of plague on ground squirrels in California. J Med Entomol 36:562-567.
  12. Dennis DT, Hughes JM. 1997. Multidrug resistance in plague. N Engl J Med 337:702-704.
  13. Doll JM, Zeitz PS, Ettestad P, et al. 1994. Cat-transmitted fatal pneumonia plague in a person who traveled from Colorado to Arizona. Ann J Trop Med Hyg 5:109-114.
  14. Eidson M, Thelsted JP, Rollag OJ. 1991. Clinical, clinicopathologic and pathologic features of plague in cats: 119 cases (1977-1985). J Am Vet Med Assoc 199:1191-1196.
  15. Eisen RJ, Eisen L, Gage KL. 2009. Studies of vector competency and efficiency of North American fleas for Yersinia pestis: state of the field and future research needs. J Med Entomol 46:737-744.
  16. Eisen RJ, Enscore RE, Biggerstaff BJ, et al. 2007. Human plague in the southwestern United States, 1957-2004: spatial models of elevated risk of human exposure to Yersinia pestis. J Med Entomol 44:530-537.
  17. Eisen RJ, Gage KL. 2009. Adaptive strategies of Yersinia pestis to persist during inter-epizootic and epizootic periods. Vet Res 40:1.
  18. Eisen RJ, Petersen JM, Higgins CL, et al. 2008. Persistence of Yersinia pestis in soil under natural conditions. Emerg Infect Dis 14:941-943.
  19. Gage KL, Dennis DT, Orloski KA, et al. 2000. Cases of cat-associated human plague in the Western US 1977-1998. Clin Infect Dis 30:893-900.
  20. Galimand M. 1999. Brief report: multiple resistance in Yersinia pestis mediated by transferable plasmid. N Engl J Med 340:677 (PMID:9278464).
  21. Galimand M, Guiyoule A, Gerbaud G, et al. 1997. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N Engl J Med 337:677-680.
  22. Gasper PW, Barnes AM, Ovan TJ. 1993. Plague (Yersinia pestis) in cats: description of experimentally-induced disease. J Med Entomol 30:20-26.
  23. Gould LH, Pape J, Ettestad P, et al. 2008. Dog-associated risk factors for human plague. Zoonoses Public Health 55:448-454.
  24. Hinnebusch BJ, Rudolph P, Chereanov P, et al. 2002. Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vector. Science 296:733-735.
  25. Hinnebusch BJ, Schwan TG. 1993. New method for plague surveillance using polymerase chain reaction to detect Yersinia pestis in fleas. J Clin Microbiol 31:1511-1514.
  26. Inglesby TV, Dennis DT, Henderson DA, et al. 2000. Plague as a biologic weapon. JAMA 283:2281-2290.
  27. Jarrett CO, Deak E, Isherwood KE, et al. 2004. Transmission of Yersinia pestis from an infectious biofilm in the flea vector. J Infect Dis 190:783-792.
  28. 26a. Jones A, Bosio C, Duffy A, et al. 2010. Protection against pneumonic plague following oral immunization with a non-replicating vaccine. Vaccine 28:5924-5929.
  29. Kilonzo BS, Gisakany DN, Sabun GA. 1993. Involvement of dogs in plague epidemiology in Tanzania: serological observations in domestic animals in Lushoto district. Scand J Infect Dis 25:503-506.
  30. 27a. Kool JL. 2004. Risk of person-to-person transmission of pneumonic plague. Clin Infect Dis 40:1166-1172.
  31. Lopez T. 1997. Plague: finding ways to stop a killer. J Am Vet Med Assoc 211:280-281.
  32. Macy DW, Gasper PW. 1990. Plague, pp 621-627. In Greene CE (ed): Infectious diseases of the dog and cat, ed 1. WB Saunders, Philadelphia.
  33. Makarovskaia LN, Tinker LA, Markovskaia EI, et al. 1996. Enhancement of treatment efficacy in experimental plague by the sequential administration of antibiotics. Antibiot Khimoter 41:25-27.
  34. 30a. McElroy KM, Blagburn BL, Breitschwerdt EB, et al. 2010. Flea-associated zoonotic diseases of cats in the USA: bartonellosis, flea-borne rickettsioses, and plague. Trends Parasitol 26:197-204.
  35. Metzger ME, Rust MK. 2002. Laboratory evaluation of fipronil and imidacloprid topical insecticides for control of the plague vector, Oropsylla montana on California ground squirrels. J Med Entomol 39:151-161.
  36. 31a. Mwengee W, Butler T, Mema S, et al. 2006. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania. Clin Infect Dis 42:614-621.
  37. 31b. Nakazawa Y, Williams R, Peterson AT. 2008. Climate change effects on plague and tularemia in the United States. Vector-borne and Zoonotic Diseases 8:1-12.
  38. Orloski KA, Eidson M. 1995. Yersinia pestis infection in three dogs. J Am Vet Med Assoc 207:316-318.
  39. Orloski KA, Lathrop SL. 2003. Plague, a veterinary perspective. J Am Vet Med Assoc 222:444-448.
  40. Parmenter RR, Yadav EP, Parmenter CA, et al. 1999. Incidence of plague associated with increased winter spring precipitation in New Mexico. Am J Trop Med Hyg 61:814-821.
  41. Perry RD. 2003. A plague of fleas—survival and transmission of Yersinia pestis. ASM News 69:336-341.
  42. Quan TJ. 1992. Yersinia pestis, pp 2888-2898. In Balows A, Truper HG, Dworkin M, et al. (eds): The prokaryotes, ed 2, vol III. Springer Verlag, New York.
  43. Russell P, Eley SM, Green M, et al. 1998. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection. J Antimicrob Chemother 41:301-305.
  44. 37a. Salkeld DJ, Stapp P. 2006. Seroprevalence rates and transmission of plague (Yersinia pestis) in mammalian carnivores. Vector-borne Zoonotic Dis 6:231-239.
  45. Sharp GJ, Eyles JE, Williamson ED, et al. 1997. Cellular and humoral responses to microencapsulated Yersinia pestis subunit vaccines following oral delivery. Biochem Soc Trans 25:338S.
  46. von Reyn CF, Weber NS, Tempest B, et al. 1977. Epidemiologic and clinical features of an outbreak of bubonic plague in New Mexico. J Infect Dis 136:489-494.
  47. Watson RP, Blanchard TW, Mense MG, et al. 2001. Histopathology of experimental plague in cats. Vet Pathol 38:165-172.
  48. Wong D, Wild MA, Walburger MA, et al. 2009. Primary pneumonic plague contracted from a mountain lion carcass. Clin Infect Dis 49:e33-338.